Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders.
Chem Commun (Camb)
; 58(85): 11913-11916, 2022 Oct 25.
Article
in English
| MEDLINE | ID: covidwho-2050566
ABSTRACT
The single-stranded RNA genome of SARS-CoV-2 contains some G-quadruplex-forming G-rich elements which are putative drug targets. Here, we performed a ligand-based pharmacophore virtual screening of FDA approved drugs to find candidates targeting such RNA structures. Further in silico and in vitro assays identified three drugs as emerging SARS-CoV-2 RNA G-quadruplex binders.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Drug Repositioning
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
English
Journal:
Chem Commun (Camb)
Journal subject:
Chemistry
Year:
2022
Document Type:
Article
Affiliation country:
D2cc03135c
Similar
MEDLINE
...
LILACS
LIS